Open AccessGlycemic Control in Diabetes Type 2 Patients in Foster Families of Brod-Posavina County During the COVID-19 Pandemic
Author(s) -
Blaženka Miškić,
Vesna Ćosić,
Marijana Knežević Praveček,
Dario Rahelić,
Blaženka Kljaić Bukvić,
Domagoj Vučić,
Ines Rajkovača Latić,
Karla Miškić
Publication year - 2021
Publication title -
collegium antropologicum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.138
H-Index - 42
eISSN - 1848-9486
pISSN - 0350-6134
DOI - 10.5671/ca.45.2.12
Subject(s) - medicine , glycemic , type 2 diabetes , diabetes mellitus , pandemic , type 1 diabetes , epidemiology , disease , medical record , gerontology , covid-19 , endocrinology , infectious disease (medical specialty)
COVID-19pandemic has changed everyday life and medical supervision of chronically illpatients. Epidemiological measures, social distancing, and limited access tomedical care impair glycemic control in patients with diabetes. Also, type 2diabetes is a risk factor for more severe form of coronavirus disease. A largeproportion of diabetic patients are placed in foster families who also adapt tothe new situation. The purpose of this study was to examine the manner and frequencyof glycemic control in patients with type 2 diabetes who are placed in fosterfamilies in the region of Brod- Posavina County. We established contact withpatients suffering from type 2 diabetes situated in foster families and their caregivers.Measurement of glycemia was performed several times a day with regular notesand the data were supplemented by an insight into the medical documentation ofpatients in the hospital information system. The study included 33 patientswith type 2 diabetes. The relationship between HbA1C with fasting andpostprandial glycemia was linear. There were no statistically significantdifferences in HbA1C regulation by type of therapy. There was a significantdifference in the number of complications according to the level of HbA1C (Hisquare test = 25.982, p <.001). The number of complications generallyincreased as HbA1C regulation was poorer. During current COVID-19 pandemic,care for patients with type 2 diabetes is significantly limited. Improvedmedical care for patients can be achieved by establishing cooperation and dailycommunication between caregivers, family physicians and, if necessary,diabetologists, especially through the use of online platforms and telephonecommunication, all with the aim of early detection of diabetes complications andadequate treatment of patients in current conditions.